Lab owner who defrauded Medicare to forfeit $187 million, Ferrari

Lab owner who defrauded Medicare to forfeit 7 million, Ferrari


Exhibit from court record: 2018 Red Ferrari Spider.

Source: U.S. DOJ

A Miami federal judge ordered a lab owner convicted of defrauding Medicare to forfeit more than $187 million worth of proceeds from the scam, including $30 million in cash, a 2018 Ferrari Spider and real estate, the Department of Justice said Wednesday.

The lab owner, Minal Patel of Atlanta, was sentenced in August to 27 years in prison for filing nearly $500 million in false claims to Medicare for sophisticated, and expensive, cancer genetic tests.

Medicare is the federally run program that provides health coverage to primarily older Americans.

The DOJ said Wednesday that the 44-year-old Patel conspired with telemedicine companies, call centers and patient brokers to convince Medicare beneficiaries to take the genetic tests through his company LabSolutions.

Telemedicine doctors robo-signed prescriptions for the tests even though they did not evaluate the patients and often did not even speak to them, according to the DOJ.

Medicare paid out more than $187 million in false claims for the tests.

In addition to the Ferrari, which retails for more than $300,000, Patel used proceeds to buy other luxury items, according to prosecutors.



Source

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
Health

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]

Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More
Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’
Health

Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

U.S. President Donald Trump speaks next to Defense Secretary Pete Hegseth during a cabinet meeting at the White House in Washington, D.C., U.S., July 8, 2025. Kevin Lamarque | Reuters President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.”  “They’re going to be tariffs […]

Read More